The global mass spectrometry market size is expected to reach USD 13.19 billion by 2033, registering a CAGR of 7.58% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rising awareness regarding early detection of chronic and infectious diseases and emerging technological advancements in diagnostic instruments are expected to significantly drive the market growth. In addition, there has been an increase in demand for cost-effective and automated techniques for disease diagnosis which is anticipated to increase the demand for mass spectrometry techniques and positively affect the growth.
The COVID-19 pandemic has boosted the demand for vaccine development due to recent advancements in virology-based research. Here, mass spectrometry has applications for the study of viral structure for SARS-CoV-2. The technique can also be used to study complex protein structures and protein-protein interactions associated with the virus. Hence, various pharmaceutical and biotechnology companies involved in COVID-19 vaccine and drug development efforts are anticipated to increase the demand for instruments and consumables.
In addition, various academic institutions and companies are indulging in product development strategies to support the demand for mass spectrometry from the proteomic market. For instance, in September 2022, the director of Northwestern’s Proteomics Center of Excellence published a paper on the development of a new imaging approach to enhance the identification of intact proteoforms. The team of researchers has built a Proteoform Imaging Mass Spectrometry (PiMS) system which is anticipated to assist mass spectrometry in various applications, including the detection of novel biomarkers, mapping of molecular tissue, and improvement in disease diagnosis.
Similarly, in October 2022, Thermo Fisher Scientific, Inc. announced the launch of mass spectrometry consumables and instrument that allows end-users in proteomics and biopharma to achieve significant breakthroughs. The instrument, known as Thermo Scientific Orbitrap Ascend Tribrid mass spectrometer, provides a new capability to direct multiple ions and enables to gain deeper insights into samples, along with rapid detection.
Request a free sample copy or view report summary: Mass Spectrometry Market Report
Based on product, the consumables & services segment is projected to grow at the fastest CAGR of 8.93% over the forecast period
Quadrupole Liquid Chromatography-Mass Spectrometry dominated the market with the largest share of 37.40% in 2025.
The proteomics segment held the largest market share of 46.22% in 2025. Mass spectrometry-based proteomics research is a comprehensive technique for quantitative profiling of proteins and studying protein-protein interactions.
The pharmaceutical and biotechnology companies segment dominated the market in 2025 due to the extensive adoption of protein sequencing using mass spectrometry in the pharmaceutical industry for drug discovery and development processes.
The North America mass spectrometry market dominated globally in 2025 with a revenue share of 42.98%. This large share is due to the presence of key market players, established academic institutions, pharmaceutical companies, and research centers, coupled with robust funding opportunities for R&D in biotechnology and drug discovery & development
Grand View Research has segmented the global mass spectrometry market based on product, technology, application, end use, and regions:
Mass Spectrometry Product Outlook (Revenue, USD Billion, 2021 - 2033)
Instruments
Consumables & Services
Mass Spectrometry Technology Outlook (Revenue, USD Billion, 2021 - 2033)
Quadrupole Liquid Chromatography-Mass Spectrometry
Gas Chromatography-Mass Spectrometry (GC-MS)
Fourier Transform-Mass Spectrometry (FT-MS)
Time-of-Flight Mass Spectrometry (TOFMS)
Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF)
Magnetic Sector Mass Spectrometry
Others
Mass Spectrometry Application Outlook (Revenue, USD Billion, 2021 - 2033)
Proteomics
Metabolomics
Glycomics
Others
Mass Spectrometry End Use Outlook (Revenue, USD Billion, 2021 - 2033)
Government & Academic Institutions
Pharmaceutical & Biotechnology Companies
Others
Mass Spectrometry Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players Mass Spectrometry Market
Agilent Technologies, Inc.
Danaher Corporation (SCIEX)
Waters Corporation
Bruker Corporation
Shimadzu Corporation
PerkinElmer, Inc.
Rigaku Corporation
LECO Corporation
JEOL Ltd.
"The quality of research they have done for us has been excellent..."